Please use this identifier to cite or link to this item:
Title: Insulin resistance in patients with chronic hepatitis C
Other Titles: Инсулинска резистенција кај пациенти со хроничен хепатитис Ц
Authors: Beti Todorovska 
Viktorija Caloska-Ivanova
Genadieva Dimitrova, Magdalena 
Elena Curakova 
Nenad Joksimovic
Keywords: hepatitis C virus,
insulin resistance,
body mass index
Issue Date: 2016
Publisher: Македонско лекарско друштво = Macedonian Medical Association
Journal: Македонски медицински преглед = Macedonian medical review
Abstract: Introduction: Insulin resistance is the most common extrahepatic manifestation associated with hepatitis C virus, which leads to developing more pronounced fibrosis and liver steatosis. The aim of the study was to assess the prevalence of insulin resistance in non-diabetic, treatment naive patients with chronic hepatitis C and to analyze the relation of insulin resistance with genotype, viral load, gender, age, laboratory parameters, inflammatory and fibrotic changes in the liver, body mass index (BMI) and the presence of steatosis. Material and methods: In this cross sectional study, 224 patients with hepatitis C viral infection were included. The patients were divided into two groups. The first group was with no insulin resistance and the second one with present insulin resistance. They were compared in terms of genotype, viral load, gender, age, inflammatory and fibrotic changes in the liver, BMI and liver steatosis. Results: Insulin resistance was present in 45.5% of patients. The following factors were associated with insulin resistance: age (p = 0.0022), inflammatory and fibrotic changes in the liver (p = 0.001, p = 0.006, respectively), steatosis (p = 0.015) and transaminase activities (for AST, p = 0,002, for ALT, p = 0.001). Conclusion: In the Republic of Macedonia, high percentage of 45.5% among non-diabetic and treatment naïve patients with chronic viral hepatitis C, had insulin resistance. Insulin resistance was more prevalent in older patients, in those with more pronounced inflammatory and fibrotic changes in the liver, in patients with steatosis and in those with higher transaminase activity.
ISSN: 0025-1097
Appears in Collections:Faculty of Medicine: Journal Articles

Files in This Item:
File Description SizeFormat 
trud IR za MMP.pdf281.34 kBAdobe PDFView/Open
Show full item record

Page view(s)

checked on Oct 22, 2020


checked on Oct 22, 2020

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.